Risk of Hospitalized Infection With DMARD or TNF-I Therapy for Ankylosing Spondylitis

Concerns have been raised in the past about the possibility of infection caused by immune suppression.

Related Videos
Related Content

Match Day's Hidden Crisis: Pediatric Rheumatology Struggling to Meet Pace

March 17th 2023

Overdrive Podcast: What's Limiting Medical Marijuana Therapy in Rheumatology?

May 19th 2022

Tumor Necrosis Factor Inhibitors Safely, Effectively Treat Patients With Juvenile Idiopathic Arthritis

March 1st 2023

Overdrive Podcast: ArthritisPower Redesign and Research

April 11th 2022

Better Self-Efficacy Linked to Better Health-Related Quality of Life in Patients With SLE

February 27th 2023

Serological Screening Recommended for Patients With JIA and a Family History of Thyroid Disease

February 27th 2023

Match Day's Hidden Crisis: Pediatric Rheumatology Struggling to Meet Pace

March 17th 2023

Overdrive Podcast: What's Limiting Medical Marijuana Therapy in Rheumatology?

May 19th 2022

Tumor Necrosis Factor Inhibitors Safely, Effectively Treat Patients With Juvenile Idiopathic Arthritis

March 1st 2023

Overdrive Podcast: ArthritisPower Redesign and Research

April 11th 2022

Better Self-Efficacy Linked to Better Health-Related Quality of Life in Patients With SLE

February 27th 2023

Serological Screening Recommended for Patients With JIA and a Family History of Thyroid Disease

February 27th 2023

Match Day's Hidden Crisis: Pediatric Rheumatology Struggling to Meet Pace

March 17th 2023

Overdrive Podcast: What's Limiting Medical Marijuana Therapy in Rheumatology?

May 19th 2022

Tumor Necrosis Factor Inhibitors Safely, Effectively Treat Patients With Juvenile Idiopathic Arthritis

March 1st 2023

Overdrive Podcast: ArthritisPower Redesign and Research

April 11th 2022

Better Self-Efficacy Linked to Better Health-Related Quality of Life in Patients With SLE

February 27th 2023

Serological Screening Recommended for Patients With JIA and a Family History of Thyroid Disease

February 27th 2023
© 2023 MJH Life Sciences

All rights reserved.